Chapter 1. Preface

1.1 Report Description and Scope
1.2 Research scope
1.3 Research methodology
1.3.1 Market Research Type
1.3.2 Market research methodology

Chapter 2. Executive Summary

2.1 Global Allergy Diagnostics Market, (2025 - 2034) (USD Billion)
2.2 Global Allergy Diagnostics Market: Snapshot

Chapter 3. Global Allergy Diagnostics Market - Industry Analysis

3.1 Allergy Diagnostics Market: Market Dynamics
3.2 Market Drivers
3.2.1 The growth of the Allergy Diagnostics Market is driven by the surging global prevalence of polysensitization—particularly in pediatric populations—the integration of AI and multiplex assays for high-throughput precision testing, and climate-driven shifts like prolonged pollen seasons and rising urban air pollution.
3.3 Market Restraints
3.3.1 The growth of the Allergy Diagnostics Market is restrained by the high capital costs of automated immunoassay analyzers that limit adoption in resource-poor regions, inconsistent global reimbursement frameworks for precision component-resolved diagnostics ($CRD$), and significant false-positive rates that necessitate expensive oral-food challenges and undermine clinical confidence.
3.4 Market Opportunities
3.4.1 The growth of the Allergy Diagnostics Market is driven by the rapid shift toward decentralized point-of-care and at-home testing, the commercialization of component-resolved molecular diagnostics for precision immunotherapy, and strategic expansion into Asia-Pacific's high-growth urban centers where air pollution and westernized diets are surging.
3.5 Market Challenges
3.5.1 The growth of the Allergy Diagnostics Market is challenged by high false-positive rates that demand expensive confirmatory tests, stringent 2026 HIPAA and AI-safety regulations for cloud-connected diagnostics, and a critical shortage of specialized allergists in emerging and rural markets.
3.6 Porter’s Five Forces Analysis
3.7 Market Attractiveness Analysis
3.7.1 Market attractiveness analysis By Products and Services
3.7.2 Market attractiveness analysis By Test Type
3.7.3 Market attractiveness analysis By Allergen

Chapter 4. Global Allergy Diagnostics Market- Competitive Landscape

4.1 Company market share analysis
4.1.1 Global Allergy Diagnostics Market: company market share, 2024
4.2 Strategic development
4.2.1 Acquisitions & mergers
4.2.2 New Product launches
4.2.3 Agreements, partnerships, cullaborations, and joint ventures
4.2.4 Research and development and Regional expansion
4.3 Price trend analysis

Chapter 5. Global Allergy Diagnostics Market - Products and Services Analysis

5.1 Global Allergy Diagnostics Market Overview: Products and Services
5.1.1 Global Allergy Diagnostics Market share, By Products and Services, 2024 and 2034
5.2 Consumables
5.2.1 Global Allergy Diagnostics Market by Consumables, 2025 - 2034 (USD Billion)
5.3 Instruments
5.3.1 Global Allergy Diagnostics Market by Instruments, 2025 - 2034 (USD Billion)
5.4 Services
5.4.1 Global Allergy Diagnostics Market by Services, 2025 - 2034 (USD Billion)

Chapter 6. Global Allergy Diagnostics Market - Test Type Analysis

6.1 Global Allergy Diagnostics Market Overview: Test Type
6.1.1 Global Allergy Diagnostics Market share, By Test Type, 2024 and 2034
6.2 In Vivo Tests
6.2.1 Global Allergy Diagnostics Market by In Vivo Tests, 2025 - 2034 (USD Billion)
6.3 In Vitro Tests
6.3.1 Global Allergy Diagnostics Market by In Vitro Tests, 2025 - 2034 (USD Billion)

Chapter 7. Global Allergy Diagnostics Market - Allergen Analysis

7.1 Global Allergy Diagnostics Market Overview: Allergen
7.1.1 Global Allergy Diagnostics Market share, By Allergen, 2024 and 2034
7.2 Inhaled Allergens
7.2.1 Global Allergy Diagnostics Market by Inhaled Allergens, 2025 - 2034 (USD Billion)
7.3 Food Allergens
7.3.1 Global Allergy Diagnostics Market by Food Allergens, 2025 - 2034 (USD Billion)
7.4 Drug Allergens
7.4.1 Global Allergy Diagnostics Market by Drug Allergens, 2025 - 2034 (USD Billion)
7.5 Other Allergens
7.5.1 Global Allergy Diagnostics Market by Other Allergens, 2025 - 2034 (USD Billion)

Chapter 8. Allergy Diagnostics Market - Regional Analysis

8.1 Global Allergy Diagnostics Market Regional Overview
8.2 Global Allergy Diagnostics Market Share, by Region, 2024 & 2034 (USD Billion)
8.3 North America
8.3.1 North America Allergy Diagnostics Market, 2025 - 2034 (USD Billion)
8.3.1.1 North America Allergy Diagnostics Market, by Country, 2025 - 2034 (USD Billion)
8.3.2 North America Allergy Diagnostics Market, by Products and Services, 2025 - 2034
8.3.2.1 North America Allergy Diagnostics Market, by Products and Services, 2025 - 2034 (USD Billion)
8.3.3 North America Allergy Diagnostics Market, by Test Type, 2025 - 2034
8.3.3.1 North America Allergy Diagnostics Market, by Test Type, 2025 - 2034 (USD Billion)
8.3.4 North America Allergy Diagnostics Market, by Allergen, 2025 - 2034
8.3.4.1 North America Allergy Diagnostics Market, by Allergen, 2025 - 2034 (USD Billion)
8.4 Europe
8.4.1 Europe Allergy Diagnostics Market, 2025 - 2034 (USD Billion)
8.4.1.1 Europe Allergy Diagnostics Market, by Country, 2025 - 2034 (USD Billion)
8.4.2 Europe Allergy Diagnostics Market, by Products and Services, 2025 - 2034
8.4.2.1 Europe Allergy Diagnostics Market, by Products and Services, 2025 - 2034 (USD Billion)
8.4.3 Europe Allergy Diagnostics Market, by Test Type, 2025 - 2034
8.4.3.1 Europe Allergy Diagnostics Market, by Test Type, 2025 - 2034 (USD Billion)
8.4.4 Europe Allergy Diagnostics Market, by Allergen, 2025 - 2034
8.4.4.1 Europe Allergy Diagnostics Market, by Allergen, 2025 - 2034 (USD Billion)
8.5 Asia Pacific
8.5.1 Asia Pacific Allergy Diagnostics Market, 2025 - 2034 (USD Billion)
8.5.1.1 Asia Pacific Allergy Diagnostics Market, by Country, 2025 - 2034 (USD Billion)
8.5.2 Asia Pacific Allergy Diagnostics Market, by Products and Services, 2025 - 2034
8.5.2.1 Asia Pacific Allergy Diagnostics Market, by Products and Services, 2025 - 2034 (USD Billion)
8.5.3 Asia Pacific Allergy Diagnostics Market, by Test Type, 2025 - 2034
8.5.3.1 Asia Pacific Allergy Diagnostics Market, by Test Type, 2025 - 2034 (USD Billion)
8.5.4 Asia Pacific Allergy Diagnostics Market, by Allergen, 2025 - 2034
8.5.4.1 Asia Pacific Allergy Diagnostics Market, by Allergen, 2025 - 2034 (USD Billion)
8.6 Latin America
8.6.1 Latin America Allergy Diagnostics Market, 2025 - 2034 (USD Billion)
8.6.1.1 Latin America Allergy Diagnostics Market, by Country, 2025 - 2034 (USD Billion)
8.6.2 Latin America Allergy Diagnostics Market, by Products and Services, 2025 - 2034
8.6.2.1 Latin America Allergy Diagnostics Market, by Products and Services, 2025 - 2034 (USD Billion)
8.6.3 Latin America Allergy Diagnostics Market, by Test Type, 2025 - 2034
8.6.3.1 Latin America Allergy Diagnostics Market, by Test Type, 2025 - 2034 (USD Billion)
8.6.4 Latin America Allergy Diagnostics Market, by Allergen, 2025 - 2034
8.6.4.1 Latin America Allergy Diagnostics Market, by Allergen, 2025 - 2034 (USD Billion)
8.7 The Middle-East and Africa
8.7.1 The Middle-East and Africa Allergy Diagnostics Market, 2025 - 2034 (USD Billion)
8.7.1.1 The Middle-East and Africa Allergy Diagnostics Market, by Country, 2025 - 2034 (USD Billion)
8.7.2 The Middle-East and Africa Allergy Diagnostics Market, by Products and Services, 2025 - 2034
8.7.2.1 The Middle-East and Africa Allergy Diagnostics Market, by Products and Services, 2025 - 2034 (USD Billion)
8.7.3 The Middle-East and Africa Allergy Diagnostics Market, by Test Type, 2025 - 2034
8.7.3.1 The Middle-East and Africa Allergy Diagnostics Market, by Test Type, 2025 - 2034 (USD Billion)
8.7.4 The Middle-East and Africa Allergy Diagnostics Market, by Allergen, 2025 - 2034
8.7.4.1 The Middle-East and Africa Allergy Diagnostics Market, by Allergen, 2025 - 2034 (USD Billion)

Chapter 9. Company Profiles

9.1 Thermo Fisher Scientific Inc.
9.1.1 Overview
9.1.2 Financials
9.1.3 Product Portfolio
9.1.4 Business Strategy
9.1.5 Recent Developments
9.2 Siemens Healthineers
9.2.1 Overview
9.2.2 Financials
9.2.3 Product Portfolio
9.2.4 Business Strategy
9.2.5 Recent Developments
9.3 Danaher Corporation
9.3.1 Overview
9.3.2 Financials
9.3.3 Product Portfolio
9.3.4 Business Strategy
9.3.5 Recent Developments
9.4 bioMérieux
9.4.1 Overview
9.4.2 Financials
9.4.3 Product Portfolio
9.4.4 Business Strategy
9.4.5 Recent Developments
9.5 HOB Biotech Group Co
9.5.1 Overview
9.5.2 Financials
9.5.3 Product Portfolio
9.5.4 Business Strategy
9.5.5 Recent Developments
9.6 Hycor Biomedical Inc.
9.6.1 Overview
9.6.2 Financials
9.6.3 Product Portfolio
9.6.4 Business Strategy
9.6.5 Recent Developments
9.7 Stallergenes Greer
9.7.1 Overview
9.7.2 Financials
9.7.3 Product Portfolio
9.7.4 Business Strategy
9.7.5 Recent Developments
9.8 R-Biopharm AG
9.8.1 Overview
9.8.2 Financials
9.8.3 Product Portfolio
9.8.4 Business Strategy
9.8.5 Recent Developments
9.9 Lincoln Diagnostics Inc.
9.9.1 Overview
9.9.2 Financials
9.9.3 Product Portfolio
9.9.4 Business Strategy
9.9.5 Recent Developments
9.10 and Others.
9.10.1 Overview
9.10.2 Financials
9.10.3 Product Portfolio
9.10.4 Business Strategy
9.10.5 Recent Developments

Frequently Asked Questions

The Allergy Diagnostics Market involves tools and services for identifying allergic sensitivities through tests like skin pricks and blood assays.

Key factors include rising allergy prevalence, technological advancements, increasing awareness, and expanding healthcare access.

The market is projected to grow from approximately USD 7.1 billion in 2026 to USD 19.5 billion by 2035.

The CAGR is expected to be 10.7% from 2026 to 2035.

North America will contribute notably, holding around 40% of the market value due to advanced infrastructure and high prevalence.

Major players include Thermo Fisher Scientific Inc., Siemens Healthineers, Danaher Corporation, bioMérieux, HOB Biotech Group Co, Hycor Biomedical Inc., Stallergenes Greer, R-Biopharm AG, and Lincoln Diagnostics Inc.

The report provides comprehensive analysis including market size, trends, segmentation, key players, regional insights, and forecasts from 2026 to 2035.

Stages include raw material sourcing, test kit manufacturing, quality assurance, distribution to labs, and end-user application with result interpretation.

Trends are shifting towards AI-integrated and point-of-care tests, while preferences favor non-invasive, accurate diagnostics for convenience.

Factors include stringent FDA approvals for test accuracy and environmental pushes for sustainable, chemical-free diagnostic materials.